Nitrofurazone (NTFZ), a nitrofuran antibiotic, was evaluated for reproductive toxicity in Swiss CD-I mice using the Reproductive Assessment by Continuous Breeding protocol. Male and female mice were cohabited for 15 weeks and exposed to NTFZ in feed at concentrations of 0, 100, 375, and 750 ppm (14-102 mg/kg/day). F o 750-ppm breeding pairs had significantly reduced fertility after 7 days of exposure to NTFZ (17% fertile compared to 98% for control pairs) and were infertile after the second litter. F o mid-dose pairs had progressively decreasing fertility (47% by the fifth litter), reduced litter size, and reduced proportion of pups born alive. Crossover breeding of control and high-dose F o animals confirmed infertility in high-dose males and reduced litter size and pup weight in high-dose females when compared to the control x control group. At necropsy, there were no effects on body weight, but F o males had reduced testis weight at the high dose and reduced epididymal sperm concentration and abnormal sperm morphology at all doses of NTFZ. Increased liver as well as kidney and adrenal weights (combined) were observed at 375 and 750 ppm; hepatic hypertrophy was noted microscopically at 750 ppm. F o females had reduced body weight, hepatic hypertrophy, and altered estrous cycles at 750 ppm and reduced ovarian weight at all doses. In the second generation, F, mice at 375 ppm had reduced postnatal survival and body weight and produced smaller F 2 litters compared to control mice. At necropsy, F, males had reduced testes weight and epididymal sperm concentration, abnormal sperm morphology, hepatic hypertrophy at 375 ppm, and borderline nephropathy at 100 and 375 ppm. F, females had decreased body, liver, and ovarian weight at 375 ppm and altered estrous cycles at 100 and 375 ppm. Thus, NTFZ at ;»100 ppm (=*14 mg/kg/day) caused adverse reproductive effects in F o male and female and F, female mice in the presence of relatively mild systemic toxicity. © 19% sodoy of Toiiccioiy.
Nitrofurazone (NTFZ), a nitrofuran antibiotic, was evaluated for reproductive toxicity in Swiss CD-I mice using the Reproductive Assessment by Continuous Breeding protocol. Male and female mice were cohabited for 15 weeks and exposed to NTFZ in feed at concentrations of 0, 100, 375, and 750 ppm (14-102 mg/kg/day). F o 750-ppm breeding pairs had significantly reduced fertility after 7 days of exposure to NTFZ (17% fertile compared to 98% for control pairs) and were infertile after the second litter. F o mid-dose pairs had progressively decreasing fertility (47% by the fifth litter), reduced litter size, and reduced proportion of pups born alive. Crossover breeding of control and high-dose F o animals confirmed infertility in high-dose males and reduced litter size and pup weight in high-dose females when compared to the control x control group. At necropsy, there were no effects on body weight, but F o males had reduced testis weight at the high dose and reduced epididymal sperm concentration and abnormal sperm morphology at all doses of NTFZ. Increased liver as well as kidney and adrenal weights (combined) were observed at 375 and 750 ppm; hepatic hypertrophy was noted microscopically at 750 ppm. F o females had reduced body weight, hepatic hypertrophy, and altered estrous cycles at 750 ppm and reduced ovarian weight at all doses. In the second generation, F, mice at 375 ppm had reduced postnatal survival and body weight and produced smaller F 2 litters compared to control mice. At necropsy, F, males had reduced testes weight and epididymal sperm concentration, abnormal sperm morphology, hepatic hypertrophy at 375 ppm, and borderline nephropathy at 100 and 375 ppm. F, females had decreased body, liver, and ovarian weight at 375 ppm and altered estrous cycles at 100 and 375 ppm. Thus, NTFZ at ;»100 ppm (=*14 mg/kg/day) caused adverse reproductive effects in F o male and female and F, female mice in the presence of relatively mild systemic toxicity. © 19% sodoy of Toiiccioiy.
Nitrofurazone (NTFZ) is a member of the nitrofuran class of compounds. Since the 1940s, the antibacterial action of ' First presented, in part , at the 31st Annual Meeting of the Society of Toxicology, Seattle, WA, February 23-27, 1992 . The Toxicologist, 12, 199. 1992 0272-0590/96 $18.00 56 Copyright C 1996 by the Society of Toxicology. All rights of reproduction in any form reserved. certain nitrofurans has been recognized (Miura and Reckendorf, 1967; Paul and Paul, 1964; Harvey, 1980) . Presentday applications in human medicine include adjunctive therapy of patients with second and third degree burns and use in skin grafting where bacterial contamination may cause graft rejection (PDR, 1991) . NTFZ is available as a topical solution, as a cream, and in a soluble dressing. Considerable use of NTFZ has also been made in veterinary medicine, suggesting inadvertent human exposure via milk and meat residues (Anonymous, 1974; Stone, 1964; Cox and Heotis, 1962; Paar, 1962; FDA, 1982; Merck, 1979) .
The National Toxicology Program (NTP) has studied NTFZ in a developmental toxicity protocol using Swiss mice and New Zealand White rabbits (NTP, 1985 (NTP, , 1987 Price et al., 1987 Price et al., , 1988 . In mice, concentrations of 0, 38, 75, 250, and 500 ppm NTFZ in feed (0-82 mg/kg/day) administered on Gestational Days 6-15 produced no treatment-related maternal toxicity. Embryo/fetal toxicity included a dose-related increase in late fetal death (0.7, 0.7, 0.7, 1.1, and 2.0%, respectively, for 0-500 ppm) and a dose-related decrease in average fetal body weight per litter, which was significant at 500 ppm (i.e., 82 mg/kg/day). The percentage malformed live fetuses per litter was not affected by treatment (NTP, 1985; Price et al, 1987) . In rabbits, administration of 0, 5, 10, 15, or 20 mg/kg/day by gavage on Gestational Days 6-19 caused no treatment-related effects at doses up to and including 15 mg/kg/day. At 20 mg/kg/day, increased maternal mortality (8%), decreased maternal weight gain during treatment, increased maternal liver weight, increased resorption of implanted conceptuses (31% vs 7% in controls), and an increased incidence of malformed live fetuses per litter (17% vs 1% in controls) were observed (NTP, 1987; Price et al., 1988) .
NTFZ exposure of Swiss mice at 100 mg/kg/day on Gestational Days 7-14 decreased reproductive and gestational indices, decreased maternal body weight gain, and decreased pup weight on Postnatal Day 1 (Hazelden, 1983 ). An increased incidence of fetal malformations was observed after pregnant ICR/JCL mice received either a single sc injection of 300 mg/kg NTFZ on Gestational Day 10 or daily injections on Gestational Days 9-11 (Nomura et al., 1976) .
Lowered fertility was observed in nontreated female mice mated to NTFZ-treated male mice (strain not specified) fed 0.2% NTFZ in the diet for 5 to 7 weeks prior to mating, indicating reproductive toxicity in maJes (Miyaji, 1971) . Other reports in the literature indicate that NTFZ may influence fertility in mammals. Hagenas et al. (1978) exposed male Sprague-Dawley rats, 60 to 90 days of age, to approximately 64 mg/kg body wt of NTFZ in their feed for 28 days. NTFZ decreased testicular and prostatic weight, increased androgen binding protein concentration in testicular homogenates, and increased serum FSH levels. These results suggest that NTFZ could have a major impact on male reproductive function.
Given the use of NTFZ as a human pharmaceutical and the demonstrated potential for NTFZ to affect reproductive function, further studies were warranted. In the present study, the Reproductive Assessment by Continuous Breeding (RACB) protocol was used to characterize the reproductive toxicity of NTFZ in mice, a species known to be adversely affected by NTFZ.
MATERIALS AND METHODS

General
The overall design of the RACB protocol has been previously reported Reel et al, 1985; NTP, 1989) . The protocol consists of four segments: a dose range-finding phase (optional), an F o cohabitation and lactation phase, a crossover mating tnal of the F o generation (conducted if F o reproductive performance is affected), and a final phase that assesses fertility of the F, generation (born and reared during the F o lactation phase). This study was conducted according to Good Laboratory Practice regulations, as outlined by die Food and Drug Administration (FDA, 1987) . All animal care procedures conformed to die established NIH guidelines (NTH, 1985) . For additional information, the reader is referred to the complete report of this study (NTP, 1992a) .
Animals and Animal Husbandry
The experimental animals were CD-I (ICR)BR outbred Swiss albino mice.
2 The animals were 6 weeks old upon arrival, 8 weeks old at the start of the dose range-finding phase, and 11 weeks old at the start of the F o cohabitation and lactation phase. At various intervals throughout the study, sera from selected mice were analyzed for antibodies against 10 or more rodent viruses 3 ; all tests were negative. During quarantine (2 to 5 weeks), animals were housed singly. Throughout the study, solid-bottom polypropylene or polycarbonate cages (11 j X 7 X 5 in.) with stainless steel wire lids 4 and AbSorb-Dri bedding 3 were used. Cages were changed at least once weekly. Deionized/filtered water and ground feed 6 in glass feeders 7 were made available ad libitum. The animal rooms were maintained at mean values of 72 + 0.2°F and 53 + 0.1% RH." Light/dark cycles were automatically controlled at 14 hr light/10 hr dark. 8 All animals were uniquely identified using a stainless steel ear tag 9 and a tail tattoo.
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Chemical. Dose Formulation, Analysis, and Treatment NTFZ (CAS No. 59-87-0)" of greater than 99% purity 12 was used. NTFZ was administered in the feed. For the dose range-finding phase, feed mixes were formulated at 0, 100, 200, 400, 600, and 900 ppm NTFZ. In the F o cohabitation and crossover mating phases, feed mixes were formulated at 0, 100, 375, and 750 ppm NTFZ, and in assessment of F, fertility, feed mixes were formulated at 0, 100, and 375 ppm NTFZ. NTFZ-dosed feed was formulated every 2 weeks and stored at refrigerated temperatures. Fresh feed was given to the animals weekly. Feed formulations were verified at approximately 1-month intervals to be within ±10% of the nominal concentration of NTFZ by high-performance liquid chromatography. 13 The exception was the 100-ppm formulation assayed during Week 4 of the F, fertility assessment, which was 117% of the nominal level. This deviation from the target dose level was not thought to cause any additional adverse effects other than would be expected from 100% of the nominal dose. Each dose level was coded so that treatment and examination of the animals were performed without knowledge of the dose levels.
Study Design and Observations
Dose range finding. Forty-eight male and forty-eight female mice at 8 weeks of age were randomly assigned to six treatment groups (8/sex/dose) by stratified randomization based on body weight. The dosing period lasted for 2 weeks. Animals were housed singly. Clinical signs were monitored, and body weight and feed and water consumption were measured weekly. At the end of Week 2, all test animals were humanely killed with no further data collection.
F o cohabitation and lactation. One hundred male and one hundred female mice, 11 weeks of age, were assigned to one of four dose groups by stratified randomization based on body weight. The control group consisted of 40 breeding pairs, and each NTFZ-treated group consisted of 18-20 breeding pairs. Doses selected for this phase were based upon the results of the dose range-finding study The dosing period encompassed 1 week of the sexes housed separately, 14 weeks monogamous cohabitation with the same F o breeding mate, and up to 6 weeks for gestation and lactation of the final litter, with F o males housed separately from F o females and their litters. Body weights and feed and water consumption were monitored during Treatment Weeks 1 and 16.
During Week 1 of exposure to NTFZ, the sexes were segregated and housed singly. During Weeks 2 through 15, animals were housed in breeding pairs within dose groups, and litters were euthanized immediately after evaluation on Postnatal Day (PND) 0. Copulatory plugs were not checked during the F o cohabitation period. Data collected during the F o cohabitation were the litter interval, number, sex, and weight of pups per litter, number of litters per breeding pair, and the PND 0 dam body weight. Because fertility was severely affected during the 14-week cohabitation period, a crossover mating trial using the control and high-dose group, and an F, 9 National Band and Tag Co., Newport, KY. 12 Confirmation of punty and identity was conducted at Research Triangle Institute (NTP/NIEHS Contract N01-ES-4506I) and involved infrared spectrometry and high-performance liquid chromatography. Purity was reconfirmed periodically during the study by high-performance liquid chromatography. See NTP (1992a) for complete details. 13 Research Triangle Institute, Research Triangle Park, NC, NTP/NIEHS Contract NO 1 -ES-45061. fertility assessment phase using the control, low-, and mid-dose groups, were conducted (see below). Starting at Week 16 of exposure, the breeding pairs were separated, and F o females were allowed to deliver and rear the final litter until PND 21. On PND 0, 4, 7, 14, and 21 of the lactation phase, pups were sexed, counted, and weighed. On PND 21, randomly selected F, pups from each dose group were weaned and housed in same-sex pairs by dose and saved for the F, fertility assessment phase (see below). After completion of the cohabitation and lactation phases, all F o animals were maintained on NTFZ-dosed feed until scheduled euthanization after the completion of the crossover mating phase.
Crossover mating trial The crossover mating trial was conducted using the control and high-dose F o animals. Three breeding groups of animals were created: (1) control male X control female, (2) high-dose male X control female, and (3) control male X high-dose female. By utilizing this breeding scheme, it is possible to delineate gender-specific fertility effects. Beginning at Week 23, animals were cohabited until a vaginal copulatory plug was observed or for 1 week, whichever occurred first. During the week of cohabitation, all animals were given control feed to avoid dosing the control animals with NTFZ. At the start of Week 24, all animals were singly housed and dosing was resumed. Upon delivery of each litter, lethality, gestation length, sex, number, and weight of the pups, and dam weight were determined. All litters were humanely killed on PND 0 following evaluation. After all litters had been delivered, vaginal smears were collected from F o females for 12 days. At Week 29 of NTFZ exposure, immediately following CO 2 asphyxiation, all F o males and females were weighed and necropsied. Liver and paired kidneys with attached adrenal weights were collected for both sexes. For males, right testis, right epididymis, prostate, and seminal vesicles with coagulating glands (glandular secretions not removed) were weighed at necropsy. The right ovary with attached oviduct was weighed for females. All tissues except ovaries with attached oviducts were fixed in 10% neutral buffered Formalin. Male reproductive tissues were embedded in glycol methacrylate (GMA), sectioned at 2.5 pm thickness, and stained with hematoxyhn/PAS.
H Ovaries with attached oviducts were fixed in Bouin's fixative for 24 hr, then rinsed and held in 70% ethanol until embedding into paraffin. All other tissues were embedded in paraffin. Sperm evaluations from the right cauda epididymis included motility, concentration, and morphology. Testicular spermatid head count and intratesticular testosterone were evaluated from the left testis. Histopathological evaluations 13 were conducted on all livers, right and left kidneys and adrenals, the right testis and epididymis, prostate, seminal vesicles, and ovary, and any gross lesions noted during the necropsy.
Fi fertility assessment
At weaning (PND 21), randomly selected F, pups from the control, low-, and mid-dose groups were housed two per cage by sex within dose group. Administration of NTFZ in feed directly to the weanlings was initiated on PND 22. At 74 ± 10 days of age, 20 males and 20 females in the control and low-dose groups were cohabited as nonsibling breeding pairs until a vaginal copulatory plug was observed or for 1 week, whichever occurred first. Because of reduced survival in the mid-dose group, only 14 pairs were cohabited, some of which were siblings. Litter data resulting from the F, cohabitation were collected as described above for the crossover mating trial. After delivery of the F 2 litters, vaginal smears were collected for 12 days. Body weight and feed and water consumption were recorded at 77 ± 10 days of age (mating) and 112 ± 10 days of age (postdelivery) during the F, fertility assessment. Maternal body weight was also recorded at discovery of an F 2 litter.
At necropsy (119 ± 10 days of age), following CO 2 asphyxiation. F, males and females were weighed and data collected as previously described for F o animals. Histopathological evaluations" were conducted on all livers, right and left kidneys and adrenals, the right testis and epididymis, and ovary, and any gross lesions noted during the necropsy.
14 Bio-Tek Research Consultants, Durham, NC. 13 PATHCO, Research Triangle Park, NC.
Statistical Analysis" 1
Most hypotheses were tested using Williams' (1986) modification of Dunn's (1964) or Shirley's (1977) nonparametric multiple comparisons procedures. Jonckheere's test (1954) was used to ascertain whether there was sufficient evidence of a dose-related response to apply Shirley's test If the p value from Jonckheere's test was less than 0.10, Shirley's test was used; otherwise, Dunn's test was applied. For data expressed as a proportion, the Cochran-Armitage test (Armitage, 1971 ) was used to test for a doserelated trend, and pairwise comparisons were performed using a x 2 test (Conover, 1971) .
To adjust for the potential effect of the number of pups per litter on the average pup weight, a parametric analysis of covariance was performed (Neter and Wasserman, 1974) . The covariate used was average litter size, including live and dead pups. Least squares estimates of dose group means, adjusted for litter size, were computed and tested for overall equality using an F test and pairwise equality using Dunnett's test (Dunnett, 1955) . Unadjusted weights (all other weight data) were analyzed with Shirley's or Dunn's test.
An arcsine transformation was performed on vaginal cytology data, and then a multivariate analysis of variance was conducted (Morrison, 1976) . Estrous cycle length was analyzed using Shirley's or Dunn's test.
RESULTS
Dose Range-Finding Study
During the 2-week period of exposure to NTFZ at 100, 200, 400, 600, or 900 ppm, there were no treatment-related deaths (data not shown). Clinical signs affecting only a few animals were observed at doses 5=400 ppm and included hyperactivity, inflamed eyelids, dehydration, and excessive circling. NTFZ had no adverse effects on body weight for either sex. Feed and water consumption tended to be decreased for males during Week 1, but this effect was no longer evident during Week 2. Water consumption for the males and females combined during Week 1 exhibited a decreasing trend and was significantly depressed at the high dose. During Week 2, males, females, and the sexes combined exhibited a decrease in water consumption, which was significantly depressed at the high dose for females and for the sexes combined (data not shown).
Based on the results from the dose range-finding study, the 900-ppm dose level was judged to be too high for use in the cohabitation phase, since it might result in an extended decrease in water consumption for both males and females. Accordingly, doses of 100, 375, and 750 ppm were chosen for the cohabitation phase.
Cohabitation and Lactation Studies
For F o animals, there were no dose-related deaths or clinical signs. All of the breeding pairs in the control (40/40) and 100-ppm dose groups (20/20), and 19/20 and 18/20 breeding pairs in the 375 and 750-ppm dose groups, respectively, survived to the end of Task 2 (Table 1) . There was no effect of treatment on male body weight or feed and water consumption (data not shown). Female body weight was significantly reduced at the high dose, reflecting the nonpregnant status of these animals. For those animals that delivered litters, body weight was not affected by treatment. During the lactational period, relative maternal feed consumption was significantly depressed at 100 ppm on PND 7 by 6%. At 375 ppm, relative maternal feed consumption was depressed at all time points; the effect was more evident with time and ranged from 16% on PND 4 to 47% on PND 21 (data not shown). Relative maternal water consumption exhibited the same, albeit more pronounced, effect. Estimated intake of NTFZ by dams during the lactational period was 27-53 mg/kg/day for the 100-ppm dose group and 108 mg/kg/day for the 375-ppm group (data not shown). F o female feed and water consumption did not exhibit any treatment-related changes at other time points during the cohabitation and lactational phases.
Exposure to NTFZ at 750 ppm significantly reduced the fertility of F o breeding pairs. Only 17% (3/18 breeding pairs) produced their first litter, compared to 98% fertility (39/40) for the control pairs (Table 1) . Only one high-dose pair produced a second litter, and the fertility of the 375-ppm group decreased from 100% (19/19) to 79% (15/19) by the second litter (data not shown). The high-dose pairs were infertile throughout the remainder of the cohabitation period, and the mid-dose pairs exhibited progressive infertility, with only 47% (9/19) of the pairs being fertile by the fifth litter, compared to 88% for controls (Table 1) . For those litters bom to the high-dose pairs, live pup weight was reduced. At the mid dose, the number of litters per pair, the average litter size, and the proportion of pups bom alive were reduced compared to those of control pairs, but the sex ratio and average absolute or adjusted pup weight were not significantly affected (Table 1) . When successive litters were examined in the mid-dose pairs, litter size was reduced 28 to 41%, compared to control pairs for litters 1, 2, and 3, although the differences were not always statistically significant. For litters 4 and 5, the mid-dose breeding pairs that were fertile, although fewer in number (9-13/19), produced litters that were similar in size to those of control breeding pairs (data not shown). There were no adverse effects of NTFZ treatment at the low dose (100 ppm; Table 1 ).
During the cohabitation phase, 1% (2/189), 3% (3/92), 14% (10/70), and 25% (1/4) of the litters in the control through high-dose groups, respectively, were bom to dams exhibiting dystocia (i.e., some aberration of labor and/or delivery) and/or inadequate postnatal care (Table 1 ). This included live or dead pups with a placenta still attached, live or dead pups still inside the amniotic sac, more than 24 hr in active labor, or pups born that were judged to be less than full gestational age. Partial cannibalization of pups was also evident in the NTFZ-treated groups.
Crossover Mating Trial and F o Necropsy
In the crossover mating trial, indices of mating and fertility were unaffected, as was the sex ratio of pups born alive, absolute live pup weight, and average number of days to litter for control males mated to 750-ppm females (Table 2) . For these pairs, however, the number of live pups per litter and the adjusted live pup weight were significantly decreased, compared to those of the control pairs, and the proportion of pups born alive, although not reduced significantly, approached statistical significance (p < 0.055) when compared to that of the control pairs ( Table 2 ). The breeding pairs of 750-ppm males and control females exhibited a significantly reduced mating efficiency (i.e., percentage cohabited females with vaginal copulatory plug; 63% vs 75% for controls) and, more importantly, produced no live litters.
Body weights of high-dose females, but not males, continued to be reduced during Weeks 22 and 27 of NTFZ exposure, and PND 0 dam weights were reduced by 20% (data not shown). There were no differences in the feed or water consumed during the 1-week cohabitation or the 3-week gestation periods.
At the F o necropsy during Week 27 (38 weeks of age), male body weight was unaffected: liver as well as kidney plus adrenal weights were significantly increased compared to those of controls in the 375-and 750-ppm groups (Table  3) . Histopathologic examination revealed treatment-related hepatic hypertrophy at the high dose. No effect of treatment was observed on right cauda epididymis weight, prostate weight, or seminal vesicle (with coagulating glands) weight. However, right corpus and caput epididymis weights were significantly decreased in the high-dose group. Right testis weight was decreased at the high dose (approximately 50% of the control value). Further evaluation of sperm parameters revealed a significant decrease in epididymal sperm concentration at both the 375 and 750 dose levels and a decrease in testicular homogenization-resistant spermatid count at all doses. The percentage abnormal sperm was significantly increased in the 100-and 375-ppm dose groups. For the one animal in the high-dose group for which sperm morphology could be evaluated, the percentage abnormal sperm was also increased (56% compared to 5% for the controls). The percentage motility exhibited a decreasing trend, and the reduction in the high-dose group (24% vs 68% for controls) was biologically relevant, although the small sample size (n = 2) precluded statistical significance. In addition, intratesticular testosterone levels (ng/g testis) were increased at the high dose. Histopathologic evaluation indicated a treatment-related increase in the incidence of seminiferous tubule degeneration and atrophy at all treatment levels. Corresponding epididymal hypospermia was observed in those animals with more severe degeneration. Testicular degeneration was characterized by several features, including a reduction in the thickness of the germinal epithelium lining the seminiferous tubule, nuclear pyknosis of the germinal epithelial cells, vacuolization within the germinal epithelium, a reduction in the maturation and number of spermatids, and the presence of occasional giant cells. Atrophy was characterized by the complete absence of germinal epithelium, leaving the tubule lined only by Sertoli cells. In the epididymis, an increased number of sloughed germinal epithelial cells and eosinophilic material were observed within the lumen of the tubules.
Evaluation of 12 days of vaginal smears revealed that the 750-ppm females differed significantly from the control females in the relative frequency of time spent in the individual estrous stages (Table 4) . Females in the 750-ppm NTFZdosed group spent more time in estrus and less time in proestrus, metestrus, or diestrus than did the control females; overall cycle length was not affected. Female body weight at necropsy was significantly decreased at the high dose; liver and kidney plus adrenal weight were unaffected (Table 4) . As with the males, histopathologic evaluation indicated treatment-related hepatic hypertrophy at the high dose. Relative ovary plus oviduct weight was decreased at all doses of NTFZ. Ovarian histology was not evaluated. 
F, Maturation, Fertility Assessment, and Necropsy
No high-dose F, animals were available for the F, evaluation. During the lactation period, average postnatal survival was reduced for mid-dose males (data not shown) and for the sexes combined in the mid-dose group (Table 5) . Lethargy, hunched back, and dehydration were noted at 375 ppm. Body weight during the preweaning period was significantly reduced for males (59% of controls) and females (61% of controls) in the 375-ppm group.
NTFZ had no effect on the F, mating index, although fertility was significantly reduced at 375 ppm (Table 6 ). The number of live pups per litter and the proportion of pups born alive were significantly decreased at 375 ppm. There was no effect on live pup weight, even though the average number of days to litter was slightly but significantly decreased at the 375-ppm dose level (Table 6 ). There was no effect of NTFZ treatment on feed or water consumption for animals selected for the F, fertility assessment (data not shown). Average dam weight on PND 0 was reduced at 375 ppm NTFZ. Estimated exposure to NTFZ was 15-21 mg/ kg/day for the 100-ppm group and 61-80 mg/kg/day for the 375-ppm group.
At the F, necropsy (119 ± 10 days of age), there was no overt effect on general toxicity as measured by male body weight (Table 7) . Liver weight and kidney plus adrenal weight were also unaffected. There was no effect on right corpus and caput epididymis, prostate, or seminal vesicle weight. Right cauda epididymis and testis weights and epididymal sperm concentration were reduced at 375 ppm, whereas the percentage abnormal sperm was increased at 375 ppm (Table 7) . Sperm motility, testicular spermatid number, and intratesticular testosterone were not adversely affected by treatment. Epididymal hypospermia (1/14 males) and degeneration and atrophy of the seminiferous tubules (3/14 males) were noted at 375 ppm NTFZ. Borderline nephropathy (in terms of severity) was noted at both 100 and 375 ppm NTFZ, whereas treatment-related hepatic hypertrophy was noted at 375 ppm NTFZ. F, females dosed with 100 ppm NTFZ spent more time in proestrus and estrus and less time in metestrus and diestrus than did controls (Table 8) . F, females dosed with 375 ppm NTFZ spent more time in proestrus, estrus, and metestrus and less time in diestrus than controls. At necropsy, F t female body weight was decreased at 375 ppm NTFZ. Liver and ovary weights were reduced at 375 ppm NTFZ, whereas kidney weight and estrous cycle length were unaffected (Table 8). No adverse histopathology was noted (data not shown).
DISCUSSION
Our data confirm and expand previously published data describing the reproductive toxicity of NTFZ (Hagenas et ai, 1978; Hickman and Elsberry, 1980; Miyaji, 1971) . NTFZ was administered in feed to F o Swiss CD-I mice at 100, 375, and 750 ppm, yielding mean exposures of 14, 56, and 102 mg/kg/day. Reproductive toxicity was clearly manifested in F o males at the mid and high doses as a progressive disruption of fertility that was related to degeneration of the seminiferous tubules observed at all exposure levels in a dose-related manner. Sperm morphology and testicular spermatid concentration were the most sensitive parameters and were significantly altered at the lowest dose (~14 mg/kg/ day). For F o females, the most sensitive indicator of treatment was ovary plus oviduct weight, which was significantly decreased at all dose levels. Reproductive toxicity, in the form of reduced litter size, was observed at 375 ppm (56 mg/kg/day) for the F, generation mating pairs. F, males exhibited adverse effects on testes weight and sperm concen- (14) ± 10 ± 8 ± 8* ± 8* ± 9* tration and morphology at 375 ppm (56 mg/kg/day). Ft females had altered estrous cycles at the lowest dose (14 mg/ kg/day). Thus, a no-observed-adverse-effect level (NOAEL) for reproductive toxicity in the F o generation was not determined. Based on relatively mild indicators of generalized toxicity, including changes in body weight, feed and water consumption, increased kidney and adrenal weight, and hepatic hypertrophy, the F o maximum tolerated dose (MTD) for NTFZ, under the conditions of this study, was 750 ppm. For the F o generation, therefore, reproductive toxicity was observed in 375 14 34 ± 1 2.4 ± 0.06 0.8 ± 0.04 14 ± 1* 37 ± 2 28 ± 2 346 ± 16 117 ± 3* 759 ± 74* 76 ± 6 6.5 ± 0.6* 9.7 ± 0.7 624 ± 224 7/11 1/14 3/14
Note. Data presented as means ± SEM; %p < 0.05, test for linear trend; *p < 0.05, pairwise comparison to controls.
the absence of significant generalized toxicity at doses as low as 100 ppm in feed (~14 mg/kg/day). For F, animals, the MTD for generalized toxicity was 375 ppm NTFZ, based on reduced body weight, hepatic hypertrophy, and borderline nephropathy. A NOAEL for reproductive toxicity was not observed for the F, generation since F, females exhibited Note. Data presented as means ± SEM; §p < 0.05, test for linear trend; *p < 0.05, pairwise comparison to controls.
" Females at 100 ppm NTFZ spent more time in proestrus and estrus, while females at 375 ppm NTFZ spent more time in proestrus, estrus, and metestrus and less time in the other stage(s) than controls. altered estrous cycles at 100 and 375 ppm, and reduced postnatal survival was observed at 375 ppm. Thus, significant reproductive toxicity was observed at 375 ppm in the presence of generalized toxicity, and mild effects on estrous cycle (which were more obvious at the higher dose) were noted in F, females at 100 ppm (14 mg/kg/day) in the absence of generalized toxicity. The F o and F, generations were thus similarly affected by NTFZ, with the F o generation more sensitive than the F, generation. Within each generation, both sexes were affected, with males being more severely affected than females in the F o generation. The testis and kidney appear to be the target organs in males, with the testis being the more sensitive indicator of toxicity. For F o females, the ovary was the primary target of toxicity; the estrous cycle in the F, females was affected at the two doses tested.
The results of the present study agree with other reports of treatment-related effects on murine reproduction, and significant effects were observed at doses that were less than or equivalent to those used in previous studies. For instance, adverse effects on reproductive competence, including reduced fertility, reduced litter size, and reduced fetal weight, were observed in male mice exposed to 0.2% (2000 ppm or 300 mg/kg/day) NTFZ in feed for 5 to 7 weeks (Miyaji, 1971) . In the present study, a reduction in fertility was observed in F o pairs after exposure to 750 ppm (102 mg/kg/ day) NTFZ in the feed for only 7 days, as evidenced by the significant decrease in pairs producing a first litter. Furthermore, reduced fertility was observed in the 375-ppm pairs (52 mg/kg/day) after 40 days of exposure. Although copula-tory plugs were not checked during F o cohabitation, it is not likely that reduced mating, per se, accounted for the decrease in the number of litters (17% fertile pairs) observed for the high-dose F o pairs, since in the crossover mating trial, 63 and 94% of the high-dose F o males and females, respectively, mated successfully with control partners.
Fertility effects of NTFZ may be due to altered gonadal function of both sexes. Hagenas et al. (1978) observed decreased testicular weight in rats exposed to 64 mg/kg/day NTFZ for 28 days. In the present study, dramatically decreased testicular weight was observed in male mice after exposure to 102 mg/kg/day NTFZ for 27 weeks. Testicular degeneration has been observed in mice exposed for 13 weeks to doses 5*620 ppm NTFZ (108 mg/kg/day) in feed (Hickman and Elsberry, 1980) . However, the present study indicates that these effects can be observed in F o mice at doses as low as 14 mg/kg/day after 27 weeks of exposure. In addition, NTFZ has been shown to inhibit sperm motility in vitro in both turkey and man (Albert et al., 1974; Ali et al., 1988) . Kari et al. (1989) observed NTFZ-induced ovarian tumors, consisting of benign mixed and granulous cell tumors, in female B6C3F, mice exposed to 150 or 310 ppm for 2 years. Ovarian atrophy and hyperplasia were also noted. Other authors have observed adverse effects of NTFZ and other nitrofuran drugs on ovarian structure and function in animals (Castro et al., 1989; Ali et al., 1987) . In the present study, ovarian weight was reduced at 100 ppm.
The results of the crossover mating trial in the present study indicate that the decrease in fertility (ability to deliver any young) is male mediated, since the high-dose F o females were fertile when mated to control males. Thus, the effects of NTFZ on the fertility of adult male mice have been shown to occur more rapidly and at lower doses than indicated by Miyaji (1971) .
The effects of NTFZ on the females are not as clear. In the present study, F o females exposed to 750 ppm NTFZ in the feed (124 mg/kg/day) and mated to control males exhibited decreased litter size and decreased adjusted live pup weight. The reduced litter size could be due to reproductive toxicity, including changes in ovulation, fertilization or implantation efficiency, or maintenance of pregnancy, as suggested by observed changes in F o female ovarian weights and estrous cycles. However, other studies suggest that developmental toxicity also plays a role in decreased reproductive competence after NTFZ treatment. Specifically, administration of NTFZ in the feed to Swiss mice during organogenesis (Gestational Days 6-15) caused increased postimplantation death and decreased pup weight at 82 mg/kg/day in the absence of significant maternal toxicity (NTP, 1985; Price et al., 1987) . However, ovarian weights and estrous cycle were not examined in that study. The possibility that the reproductive and developmental effects observed in the F o females may also be secondary to reduced body weight (decreased by 20% at the high dose at delivery) must also be considered, since Chapin et al. (1993) found that feed restriction, resulting in a similar reduction of body weight in female Swiss mice, decreased litter size to 22% of control values (2.0 vs 9.1 for controls) and adjusted pup weight (74% of control values) when mating to control males occurred after 17 weeks of feed restriction (NTP, 1992b; Chapin et al., 1993) . In the present study, however, although the F o females exhibited body weight that was 80% of controls at delivery after the crossover mating trial and 87% of controls at necropsy, the developmental effects were limited to a litter size that was 50% of controls and an adjusted live pup weight that was 87% of controls. These effects were biologically and statistically significant, but they are less than what would be expected if the reduction in body weight was due to feed (and therefore nutritional) restriction alone (Chapin et al., 1993) . Observation of the animals in the present study indicate that much of the dosed feed was scattered by the animals in the cages and could not, therefore, be accurately measured, so we are unsure if feed consumption was altered. Thus, the possible contribution of a mild nutritional deficit to the overall decline in reproductive function for females cannot be completely dismissed.
The effects of NTFZ on labor, delivery, and postnatal development were previously unreported. Thus, the observations of dystocia in the F o generation at 375 ppm (56 mg/ kg/day) and 750 ppm (102 mg/kg/day) NTFZ extend the literature of reproductive and developmental toxicity of NTFZ. Likewise, F, effects, including decreased postnatal survival and body weight, decreased F 2 litter size, testicular degeneration, and alterations of F, estrous cycle at 375 ppm add significantly to the description of NTFZ toxicity. Postnatal effects, including decreased survival and body weight, may be due to toxic effects of NTFZ in the milk of treated mothers. Other effects on the mother, including altered milk letdown or milk quality, may also be contributing to the postnatal toxicity observed. Further investigations designed to separate effects of maternal function from prenatally induced effects on the offspring may be warranted.
Results from the present study suggest that NTFZ probably exerts toxic effects at multiple sites in adult and developing animals. NTFZ may disrupt endocrine function since females exhibited an altered estrous cycle. In males, the testis appears to be a primary target, although the mechanism of toxicity is not clear. Intratesticular testosterone was dramatically increased in the F o high-dose males, but this was most likely due, at least in part, to the decrease (~60%) in testis weight (mainly seminiferous tubules) which can occur without any change in testosterone (Fail et al., 1992) . Total testosterone in F o males, calculated as total nanograms of testosterone per testes, was approximately 74, 72, 93, and 81 ng for the control through high-dose males, respectively. The effect of NTFZ on total testosterone was more pronounced in the F, males at comparable doses; for F, males in the control and 100-and 375-ppm dose groups, testosterone was 27, 31, and 73 ng/testes, respectively. Overall, this represents a nearly 3-fold change in F| males. Thus, testosterone production is unchanged or mildly elevated in Ft males and markedly increased in F o males. Classic testosteronesensitive organs, such as the prostate, were not altered in weight. This also reinforces the notion that testicular toxicity was not due to removal of testosterone support. It is possible that NTFZ interferes with pituitary support of gonadal function by disrupting LH, FSH, and/or prolactin secretion patterns or release, causing hyperstimulation of the pituitary and hyperstimulation of the testes in turn. However, we do not currently have the data to support this hypothesis. Furthermore, other research in rats and turkeys does not support this idea (Ali et al, 1988; Hagenas et al, 1978) . In male turkeys, LH was reduced 10-fold and testosterone reduced 2-fold in plasma after oral treatment for 14 days with 20 mg/kg furazolidone, a nitrofuran drug (Ali et al, 1988) . In agreement with our data, other authors reported an increase or no change in testicular testosterone production and the weight of androgen-dependent organs in rats (Nelson and Patanelli, 1965) . Thus, it is difficult to interpret our data in light of these conflicting reports.
Observation of decreased caput epididymis weight, decreased testicular weight, and increased testosterone concentrations in our study may suggest diminished secretory activity by these organs. This hypothesis would fit with evidence of increased testicular androgen-binding protein (ABP) concentrations in testicular homogenates in rats after treatment with NTFZ at 64 mg/kg body w in the feed for 28 days (Hagenas et al. 1978) .
Perhaps local control mechanisms within the testis are responsible for diminished sperm production or sperm abnormalities following increased testosterone concentrations. Disrupted or stimulated Sertoli cell function would explain high FSH and increased ABP in the face of high testosterone. Disrupted Sertoli cell functions could also explain the increased number of abnormal spermatozoa in the cauda epididymis. However, abnormalities in sperm morphology could arise not only during spermatogenesis, but also during testicular or epididymal transit.
A perplexing aspect of the relationship of testicular weight, intratesticular testosterone, and testicular spermatid counts is that it differs markedly for the two generations. In F o males, normal or slightly increased testosterone is associated with decreasing testis weight and decreasing spermatids. In F o males, spermatid counts decreased in the face of normal testosterone concentrations, whereas the F, males, exposed to NTFZ as embryos and during sexual maturation, had near normal spermatid numbers in the face of a supraphysiological increase in testosterone. The older male thus appears to be more sensitive to NTFZ, causing depressed spermatid number and testicular atrophy. Perhaps NTFZ could affect enzymatic balance in steroidogenic tissue or alter testosterone metabolism or secretion.
The present study indicates that significant peri-and postnatal toxicity can also be associated with NTFZ exposure at doses of 375 ppm and greater, observed primarily as preand postweaning failure to thrive. This could be due to a lack of appropriate endocrine support with respect to milk production (prolactin) and growth and development (growth hormone). These data suggest a direct effect of NTFZ on the developing organism. Future studies of NTFZ should be targeted toward effects on the endocrine system of the parental generation and their offspring, the direct effects of NTFZ on the reproductive tissues of adults and developing animals, and the mechanism of these toxic effects on reproductive function and growth.
